Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy

BACKGROUND: The HORSE-BC study previously demonstrated that second-line endocrine therapy (ET) for patients with acquired endocrine-resistant metastatic breast cancer (MBC) still provided a clinically meaningful benefit. Herein, we investigated the health-related quality of life (HRQOL) in the HORSE...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikawa, Yuichiro, Hagiwara, Yasuhiro, Fujisawa, Tomomi, Araki, Kazuhiro, Iwamoto, Takayuki, Sangai, Takafumi, Shien, Tadahiko, Takao, Shintaro, Nishimura, Reiki, Takahashi, Masato, Toyama, Tatsuya, Aihara, Tomohiko, Mukai, Hirofumi, Taira, Naruto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707754/
https://www.ncbi.nlm.nih.gov/pubmed/36445924
http://dx.doi.org/10.1371/journal.pone.0278344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707754/
https://www.ncbi.nlm.nih.gov/pubmed/36445924
http://dx.doi.org/10.1371/journal.pone.0278344

Ejemplares similares